mergers-and-acquisitions News

Warner Bros. Discovery Stock Gains on Takeover Bids
Mergers & Acquisitions
2mo ago

Warner Bros. Discovery Stock Gains on Takeover Bids

Paramount, Comcast, and Netflix are reportedly in contention to acquire the media giant or its key assets, sparking speculation of a bidding war.

Warner Bros. Discovery Fields Bids From Media Giants
Mergers & Acquisitions
2mo ago

Warner Bros. Discovery Fields Bids From Media Giants

Reports indicate Paramount, Comcast, and Netflix have all submitted offers, signaling a potential tectonic shift in the streaming and entertainment landscape.

GE HealthCare Surges on $2.3B Intelerad Acquisition
Mergers & Acquisitions
2mo ago

GE HealthCare Surges on $2.3B Intelerad Acquisition

The all-cash deal for the medical imaging software firm aims to accelerate GEHC's push into cloud-based, AI-driven diagnostics.

Solventum Surges 5% on $725 Million Deal for Acera Surgical
Mergers & Acquisitions
2mo ago

Solventum Surges 5% on $725 Million Deal for Acera Surgical

The acquisition marks Solventum's first major strategic move since its spin-off from 3M, significantly expanding its advanced wound care portfolio.

Abbott Strikes $21 Billion Deal for Exact Sciences
Mergers & Acquisitions
2mo ago

Abbott Strikes $21 Billion Deal for Exact Sciences

Acquisition of Cologuard maker marks a strategic pivot into the rapidly growing cancer diagnostics market as Covid-testing revenue wanes.

Atkore Explores Sale Amid Activist Pressure, Overshadowing Weak Earnings
Mergers & Acquisitions
2mo ago

Atkore Explores Sale Amid Activist Pressure, Overshadowing Weak Earnings

Shares rise over 2% as electrical parts maker announces expanded strategic review and board seat for activist investor Irenic Capital, despite reporting a Q4 net loss.

Artisan Partners Opposes $25B Axalta-Akzo Nobel Merger
Mergers & Acquisitions
2mo ago

Artisan Partners Opposes $25B Axalta-Akzo Nobel Merger

Major investor urges shareholders to reject the all-stock deal, arguing it undervalues Axalta and favors an acquirer with a 'track record of value stagnation.'

Exact Sciences Soars 14% on Report of Abbott Takeover Interest
Mergers & Acquisitions
2mo ago

Exact Sciences Soars 14% on Report of Abbott Takeover Interest

Shares in the $13.2 billion cancer diagnostics firm were halted after a report named healthcare giant Abbott Laboratories as a potential acquirer, signaling a major strategic push into oncology.